Atlas Trials

Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19)

Clinical trial NCT04597216 · UNKNOWN

Trial details

NCT number
NCT04597216
Sponsor
University Hospital, Grenoble
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Covid19
Start date
2020-10-15
Primary completion
2020-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.